Table 2.

Clinical outcomes.

Clinical outcomes	All patients (N = 137)
Follow-up time, days (IQR)	661.0 (334.5–939.5)
Decompensation event, n (%)	57 (41.6%)
Ascitic complication, n (%)	20 (14.6%)
Variceal bleeding, n (%)	10 (7.3%)
Hepatic encephalopathy, n (%)	24 (17.5%)
ACLF, n (%)	33 (24.1%)
Acute kidney injury, n (%)	28 (20.4%)
Bacterial infection, n (%)	34 (24.8%)
HCC, n (%)	3 (2.2%)
TIPS implantation, n (%)	11 (8.0%)
Liver transplantation, n (%)	11 (8.0%)
Death, n (%)	32 (23.4%)
Liver-related death, n (%)	24 (17.5%)

ACLF, acute-on-chronic liver failure; HCC, hepatocellular carcinoma; TIPS, transjugular intrahepatic portosystemic shunt.